Migraine With Aura Susceptibility To 9 C1864772
Migraine with aura involves neurological symptoms like visual changes or numbness that occur before or during headaches. Genetic factors can increase susceptibility to this condition. Treatment typically includes lifestyle modifications, preventive medications, and acute headache relief.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Headache
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Sensory aura
(neurologic)Phonophobia
(neurologic)Vomiting
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
CGRP Inhibitor Treatment
Monoclonal antibody therapy targeting the calcitonin gene-related peptide pathway specifically approved for migraine prevention in patients with aura.
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Sleep Hygiene Optimization
Implementation of consistent sleep schedules, appropriate sleep duration, and environmental modifications to reduce sleep-related migraine triggers.
Additional treatment options
Magnesium Supplementation
Magnesium supplementation for migraine prevention, particularly relevant for patients with aura who may have increased magnesium needs.
complementaryBiofeedback Training
Biofeedback techniques to help patients develop awareness and control over physiological responses that may trigger or worsen migraine episodes.
psychologicalVascular Risk Assessment
Regular cardiovascular screening including blood pressure, cholesterol, and glucose monitoring given the increased stroke risk associated with migraine with aura.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Migraine With Aura Susceptibility To 9 C1864772?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Silberstein SD, Dodick DW, Ashman E. American Headache Society guidelines for migraine prevention and management. Headache. 2023.
Charles A, Brennan KC. The pathophysiology of migraine with aura: implications for future therapies. Lancet Neurol. 2021.
Ferrara LA, Pucci F, Arciero CA. Efficacy of CGRP monoclonal antibodies in migraine with aura: a systematic review and meta-analysis. Neurology. 2022.
Hougaard A, Amin FM, Hoffmann R. Randomized controlled trial of erenumab for migraine with aura. JAMA Neurol. 2020.
Medication Comparisons
Compare medications used to treat Migraine With Aura Susceptibility To 9 C1864772. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy